# Efficacy Study of the Use of Sequential DFP-DFO Versus DFP

> **NCT00733811** · PHASE4 · COMPLETED · sponsor: **Azienda Ospedaliera V. Cervello** · enrollment: 213 (actual)

## Conditions studied

- Beta-Thalassemia
- Thalassemia Major

## Interventions

- **DRUG:** Deferiprone (DFP) and Deferoxamine (DFO)
- **DRUG:** Deferiprone (DFP)

## Key facts

- **NCT ID:** NCT00733811
- **Lead sponsor:** Azienda Ospedaliera V. Cervello
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2008-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733811, "Efficacy Study of the Use of Sequential DFP-DFO Versus DFP". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00733811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*